This nonrandomized clinical trial evaluates the long-term safety and efficacy of continuous treatment with deucravacitinib through 3 years in the POETYK PSO-1, PSO-2, and long-term extension trial.
This survey study evaluates how much emphasis is placed on financial vs nonfinancial factors in employer decision-making about health care benefits.
Explore the top headlines of the week including innovation in scalp treatment, therapeutic updates in rosacea, and acne vulgaris insights from James Del Rosso, DO.
This randomized clinical trial assesses the efficacy and adverse events of baricitinib combined with narrowband UV-B in adults with severe, active, nonsegmental vitiligo.
This cross-sectional study describes trends in hospital and private equity affiliation in primary care and examines variation in negotiated prices paid by commercial insurers to…
This Viewpoint discusses scientific, medical, and public health actions, including withdrawing from the World Health Organization, taken so far during the first week of the…
This systematic review and analysis examines the prevalence of 20 psychiatric disorders in persons with epilepsy compared with persons without epilepsy.
This cross-sectional study explores US prescription fills, retail spending, and prices of low-dose doxepin for insomnia and the possible cost savings to patients had they…
In case you missed it, this week we had news about awareness resources from the Skin Cancer Foundation, burn care disparities in skin of color,…
This Viewpoint evaluates the health impacts of climate change among older adults and provides recommendations to safeguard their health and wellbeing.
